Skeletal Phenotyping Core

骨骼表型核心

基本信息

  • 批准号:
    10451722
  • 负责人:
  • 金额:
    $ 28.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-19 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Identification of the structural, architectural, cellular and molecular basis for the skeletal phenotypes that result from genetic/pharmacologic interventions and disease states is essential for translating scientific discoveries into therapeutic innovations. The goal of the Skeletal Phenotyping Core is to provide cost-efficient, state of the art, quality-controlled skeletal phenotyping services, continuing to fulfill the unmet needs of early stage investigators who are transitioning to an independent career in skeletal biology, of established investigators who are new to skeletal biology and of established skeletal biologists. Key missions of the Skeletal Phenotyping Core include education, mentoring and incorporation of novel and innovative services to meet the needs of the constituent investigators. Consultation regarding experimental design, specimen handling and data analysis is provided by Core directors, to ensure that the maximal amount of data can be obtained from each specimen/subject. The Core will conduct didactic teaching sessions, hands-on workshops and seminars designed to educate investigators and to foster collaboration among investigators. A special focus of the Core will continue to be mentorship of early stage investigators and of those investigators new to skeletal biology. This infrastructure and these activities will continue to: 1) enhance the productivity and expand the scope of research being conducted by the Core investigators, 2) promote innovation and incorporation of novel technologies into core services, 3) foster synergy across a large and diverse community interested in skeletal research, ultimately leading to levels of success greater than the sum of the individual investigators’ projected achievements. These goals will be achieved by two specific aims: Aim 1) Provide efficient, high-quality, state- of-the-art skeletal phenotyping services that are not readily supported by individual research grants in a timely fashion; Aim 2) Provide training, and educational services to support new investigators in skeletal biology and to facilitate collaboration among core investigators. In summary, the Skeletal Phenotyping Core will continue to enhance the research productivity of a large and diverse community of investigators in skeletal biology by ensuring accurate, efficient and comprehensive analyses of skeletal phenotypes.
确定导致骨骼表型的结构、建筑、细胞和分子基础 从遗传/药理学干预和疾病状态是必不可少的转化科学发现 转化为治疗创新。Skeleton表型核心的目标是提供具有成本效益的, 艺术,质量控制的骨骼表型服务,继续满足早期阶段未满足的需求 正在过渡到骨骼生物学独立职业的研究者,已建立的研究者 他们是骨骼生物学的新手,也是公认的骨骼生物学家。Skeleton的主要任务 表型分析核心包括教育,指导和纳入新颖和创新的服务,以满足 调查人员的需求。关于实验设计、样品处理和 数据分析由核心主管提供,以确保可以从 每个样本/受试者。该中心将举办教学课程、实践讲习班和研讨会 旨在教育调查人员并促进调查人员之间的合作。核心的一个特别重点 将继续指导早期研究者和那些刚接触骨骼生物学的研究者。 这些基础设施和这些活动将继续:1)提高生产力,扩大 核心研究者正在进行的研究,2)促进创新和新的 3)在对核心服务感兴趣的庞大而多样化的社区中促进协同作用, 研究,最终导致的成功水平大于个人研究者的预测总和 成绩这些目标将通过两个具体目标来实现:目标1)提供高效,高质量,状态- 最先进的骨骼表型分析服务,这些服务不容易及时得到个人研究赠款的支持。 目标2)提供培训和教育服务,以支持骨骼生物学的新研究者, 促进核心调查人员之间的合作。总之,Skeleton表型核心将继续 通过以下方式提高骨骼生物学研究人员的大型和多样化社区的研究生产力 确保骨骼表型的准确、高效和全面分析。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY L BOUXSEIN其他文献

MARY L BOUXSEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY L BOUXSEIN', 18)}}的其他基金

Enhancing Workforce Diversity in the Bone, Mineral, and Musculoskeletal Field
增强骨骼、矿物质和肌肉骨骼领域的劳动力多样性
  • 批准号:
    10651145
  • 财政年份:
    2023
  • 资助金额:
    $ 28.16万
  • 项目类别:
Delineating mechanisms of skeletal fragility in older adults with Type 1 Diabetes
描述患有 1 型糖尿病的老年人骨骼脆弱的机制
  • 批准号:
    10604862
  • 财政年份:
    2023
  • 资助金额:
    $ 28.16万
  • 项目类别:
Long term fracture risk and change in peripheral bone in the oldest old men: The MrOS study
最年长男性的长期骨折风险和周围骨变化:MrOS 研究
  • 批准号:
    10304929
  • 财政年份:
    2020
  • 资助金额:
    $ 28.16万
  • 项目类别:
Long term fracture risk and change in peripheral bone in the oldest old men: The MrOS study
最年长男性的长期骨折风险和周围骨变化:MrOS 研究
  • 批准号:
    10264783
  • 财政年份:
    2020
  • 资助金额:
    $ 28.16万
  • 项目类别:
Long term fracture risk and change in peripheral bone in the oldest old men: The MrOS study
最年长男性的长期骨折风险和周围骨变化:MrOS 研究
  • 批准号:
    10413238
  • 财政年份:
    2020
  • 资助金额:
    $ 28.16万
  • 项目类别:
Biomechanical mechanisms underlying skeletal fragility in older adults with Type 1 diabetes
患有 1 型糖尿病的老年人骨骼脆弱的生物力学机制
  • 批准号:
    10012242
  • 财政年份:
    2019
  • 资助金额:
    $ 28.16万
  • 项目类别:
Determinants of bone microarchitectural compromise in youth with type 1 diabetes
1 型糖尿病青少年骨微结构受损的决定因素
  • 批准号:
    10693855
  • 财政年份:
    2019
  • 资助金额:
    $ 28.16万
  • 项目类别:
Determinants of bone microarchitectural compromise in youth with type 1 diabetes
1 型糖尿病青少年骨微结构受损的决定因素
  • 批准号:
    10017184
  • 财政年份:
    2019
  • 资助金额:
    $ 28.16万
  • 项目类别:
Skeletal Phenotyping Core
骨骼表型核心
  • 批准号:
    10626809
  • 财政年份:
    2019
  • 资助金额:
    $ 28.16万
  • 项目类别:
Biomechanical mechanisms underlying skeletal fragility in older adults with Type 1 diabetes
患有 1 型糖尿病的老年人骨骼脆弱的生物力学机制
  • 批准号:
    10017186
  • 财政年份:
    2019
  • 资助金额:
    $ 28.16万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.16万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了